From Detroit, Michigan, USA:
Our eight year old was diagnosed with diabetes a year ago which we were told was caused by a virus that triggered his immune system to launch an attack on the cells in his pancreas, thus stopping insulin production. A friend of mine sent me an article she received regarding the discovery of a protein, PGC-1, which is believed to be the "switch" that regulates the liver's production of glucose. The researchers said sugar builds up dangerously in the bloodstream of people with diabetes because this switch doesn't turn off. Finding this key blood sugar controller could yield new diabetes drugs.
We have never heard anything about this. Is this true? If so, what impact, then, would this new discovery have in the future treatment/management/cure of our child's diabetes?
I believe that the paper you friend was referring to was Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 in the latest issue of Nature (Sept.13;413, 2001).
PGC-1 is indeed an important recently discovered (transcription) factor that activates a number of enzymes that are promoters of gluconeogenesis (the conversion of protein to glucose). As you can imagine, its role is more to raise blood sugar during hypoglycemia than to depress it in hyperglycemia.
As it is, there is a drug called Glucophage [metformin] which is widely used in type 2 diabetes and also, but to a much lesser extent, in conjunction with insulin in type 1 diabetes, to better control high blood sugars by the restriction of gluconeogenesis.
Original posting 25 Sep 2001
Posted to Research: Other Research
Last Updated: Tuesday April 06, 2010 15:09:24
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.